EL EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2023

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2023

Disclosure of Share Capital and Voting Rights Outstanding

as of January 31, 2023

(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Charenton-le-Pont, France (February 15, 2023 - 6:00 pm) – As of January 31, 2023, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.

 January 31, 2023
Shares outstanding          447,690,0021
Number of real voting rights (excluding treasury shares)445,340,227
Theoretical number of voting rights (including treasury shares)447,690,002

It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica’s by-laws2.

For further information, please consult the Prospectus which received Visa No. 18-460 from the AMF on September 28, 2018 and its Securities Note Supplement which received Visa No. 18-494 from the AMF on October 23, 2018, available on the website .

1Including 42,672 shares delivered but not yet registered as of January 31, 2023.

2EssilorLuxottica’s by-laws are available on the Company’s website under the section Governance / Publications.

Attachment



EN
15/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EssilorLuxottica SA

 PRESS RELEASE

EssilorLuxottica to acquire Optegra clinics, another leap forward in i...

EssilorLuxottica to acquire Optegra clinics, another leap forward in its med-tech strategy EssilorLuxottica to acquire Optegra clinics,another leap forward in its med-tech strategy Acquisition of leading ophthalmology platform from MidEuropa will advance the Group’s development of the most comprehensive and digital-forward patient journey Paris, France and London, United Kingdom (30 May 2025) – EssilorLuxottica and MidEuropa announced today they entered into an agreement for EssilorLuxottica to acquire Optegra, a fast-growing and highly integrated ophthalmology platform operating in five...

 PRESS RELEASE

EssilorLuxottica va acquérir les cliniques Optegra, une nouvelle étape...

EssilorLuxottica va acquérir les cliniques Optegra, une nouvelle étape clé dans sa stratégie med-tech EssilorLuxottica va acquérir les cliniques Optegra, une nouvelle étape clé dans sa stratégie med-tech Avec l’acquisition de cette plateforme d'ophtalmologie de premier plan auprès de MidEuropa, le Groupe vise à accélérer le développement d’un parcours patient plus complet et digitalisé Paris, France et Londres, Royaume-Uni (30 mai 2025) – EssilorLuxottica et MidEuropa annoncent aujourd’hui avoir conclu un accord prévoyant l’acquisition d’Optegra par EssilorLuxottica. Optegra est une pla...

 PRESS RELEASE

EssilorLuxottica acquisisce le cliniche del gruppo Optegra e continua ...

EssilorLuxottica acquisisce le cliniche del gruppo Optegra e continua a crescere nel med-tech EssilorLuxottica acquisisce le cliniche del gruppo Optegrae continua a crescere nel med-tech  L’acquisizione di una delle principali piattaforme oftalmiche europee da MidEuropa permetterà al Gruppo di offrire ai pazienti un’esperienza sempre più digitale, completa e innovativa Parigi, Francia e Londra, Regno Unito (30 maggio 2025) – EssilorLuxottica e MidEuropa annunciano di aver firmato un accordo per l’acquisizione di Optegra, una piattaforma oftalmica in forte espansione e perfettamente integ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch